21 completed, 10 terminated, 4 recruiting, 3 unknown. 43 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 43 | Completed 21, Terminated 10, Recruiting 4, Unknown 3, Withdrawn 3, Active not recruiting 1, Not yet recruiting 1 |
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Panuveitis: new trials by email Literature Review of Panuveitis trials Research Report on Panuveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's Syndrome Corticosteroids + Rivaroxaban, Corticosteroids alone - Behcet Syndrome | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 134 | 2025-06-24 | 2026-04-23 |
| Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease Placebo plus immunosuppression, Rivaroxaban plus immunosupression - Behcet Disease, Behcet Disease and Vascular Involvement | Phase 3 | Not yet recruiting | Marmara University | 110 | 2025-04-30 | 2025-04-13 |
| A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis Brepocitinib PO QD, Placebo PO QD - Uveitis, Posterior, Uveitis, Intermediate | Phase 3 | Active not recruiting | Priovant Therapeutics, Inc. | 371 | 2024-09-11 | 2026-01-12 |
| A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease Hemay005, Placebo - Behçet's Disease | Phase 3 | Recruiting | Ganzhou Hemay Pharmaceutical Co., Ltd | 162 | 2023-11-13 | 2025-04-08 |
| A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis Apremilast - Behçet's Disease, Juvenile Psoriatic Arthritis | Phase 3 | Recruiting | Amgen | 48 | 2023-03-23 | 2025-12-01 |
| The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment Yutiq 0.18 MG Drug Implant, Sham Injection - Uveitis, Uveitis, Posterior | Phase 3 | Completed | Texas Retina Associates | 10 | 2022-10-05 | 2026-10-05 |
| Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases Triamcinolone Acetonide - Central Serous Chorioretinopathy, Irvine-Gass Syndrome | Phase 2 / Phase 3 | Unknown | Benha University | 50 | 2022-04-14 | 2022-04-20 |
| Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert Sham Injector, FAI Insert - Uveitis, Uveitis, Posterior | Phase 3 | Terminated | EyePoint Pharmaceuticals, Inc. | 12 | 2021-10-13 | 2024-12-19 |
| Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease Apremilast, Placebo - Behçet Disease | Phase 3 | Recruiting | Amgen | 60 | 2021-09-09 | 2026-07-24 |
| Multicenter, Randomized Study Evaluating the Value of Antitubercular Treatment During Recurent Anterior Uveitis (URBA) Antitubercular treatment (RIFATER ©), Ethambutol, RIFINAH © - Uveitis, Anterior | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 116 | 2019-11-01 | 2019-10-07 |
| Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease Infliximab, Cyclophosphamide - Behcet's Disease, Vasculitis | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 53 | 2018-05-25 | 2023-07-03 |
| Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis Interferon Alfa-2A, Cyclosporine Pill - Behçet Disease, Uveitis | Phase 3 | Completed | Peking Union Medical College Hospital | 28 | 2017-06-30 | 2021-02-23 |
| Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis 4 mg CLS-TA Suprachoriodal Injection - Uveitis, Uveitis, Posterior | Phase 3 | Completed | Clearside Biomedical, Inc. | 38 | 2017-04-04 | 2021-06-23 |
| Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis Dexamethasone Phosphate Ophthalmic Solution, Prednisolone Acetate Ophthalmic (1%) - Anterior Uveitis | Phase 3 | Completed | Eyegate Pharmaceuticals, Inc. | 251 | 2016-01-16 | 2018-07-26 |
| Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis 4mg CLS-TA Suprachoriodal Injection, Sham Procedure - Uveitis, Uveitis, Posterior | Phase 3 | Completed | Clearside Biomedical, Inc. | 160 | 2015-11-17 | 2021-05-28 |
| A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease Infliximab - Behcet Disease | Phase 3 | Completed | Janssen Korea, Ltd., Korea | 33 | 2015-07-22 | 2019-10-17 |
| Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis Sham Injection, FAI Insert - Posterior Uveitis, Intermediate Uveitis | Phase 3 | Completed | EyePoint Pharmaceuticals, Inc. | 153 | 2015-06-02 | 2020-07-21 |
| A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease Apremilast, Placebo - Behçet's Syndrome | Phase 3 | Completed | Amgen | 207 | 2014-12-30 | 2021-07-22 |
| Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis Placebo, Gevokizumab - Behcet's Disease Uveitis | Phase 3 | Terminated | XOMA (US) LLC | 4 | 2014-11-01 | 2015-12-29 |
| Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X) Gevokizumab - Chronic Uveitis | Phase 3 | Terminated | Institut de Recherches Internationales Servier | 71 | 2014-08-01 | 2020-01-03 |
Showing 20 of 43. Sign in to see all of them.
Uveitis (23) · Uveitis, Posterior (21) · Uveitis, Intermediate (20) · Behcet Syndrome (13) · Uveitis, Anterior (9) · Chorioretinitis (2) · Oral Ulcer (2) · Arthritis, Juvenile (1) · Cardiovascular Diseases (1) · Central Serous Chorioretinopathy (1) · Dermatitis (1) · Inflammation (1) · Macular Edema (1) · Multifocal Choroiditis (1)
Eye Diseases (43) · Uveal Diseases (43) · Uveitis (20) · Skin Diseases (14) · Skin and Connective Tissue Diseases (14) · Vascular Diseases (14) · Cardiovascular Diseases (13) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (13) · Genetic Diseases, Inborn (13) · Hereditary Autoinflammatory Diseases (13) · Mouth Diseases (13) · Skin Diseases, Genetic (13) · Skin Diseases, Vascular (13) · Stomatognathic Diseases (13)
secukinumab (6) · Triamcinolone Acetonide (3) · apremilast (3) · salicylhydroxamic acid (3) · Cyclosporine (2) · Dexamethasone (2) · Fluocinolone Acetonide (2) · Infliximab (2) · Interferon alpha-2 (2) · Rivaroxaban (2) · gevokizumab (2) · Adalimumab (1) · Adrenal Cortex Hormones (1) · Benzalkonium Compounds (1) · Bevacizumab (1)
Novartis Pharmaceuticals (5) · XOMA (US) LLC (4) · Amgen (3) · Assistance Publique - Hôpitaux de Paris (3) · Lux Biosciences, Inc. (3) · Allergan (2) · Clearside Biomedical, Inc. (2) · EyePoint Pharmaceuticals, Inc. (2) · Eyegate Pharmaceuticals, Inc. (2) · Sirion Therapeutics, Inc. (2) · AbbVie (1) · Asociación para Evitar la Ceguera en México (1) · Benha University (1) · Ganzhou Hemay Pharmaceutical Co., Ltd (1) · Institut de Recherches Internationales Servier (1)
United States (22) · Germany (14) · France (13) · Israel (13) · United Kingdom (12) · Spain (11) · India (10) · Greece (9) · Turkey (Türkiye) (9) · Austria (7) · Canada (7) · Italy (7) · Switzerland (7) · Brazil (6) · South Korea (6)
Eddy Anglade, M.D. (3) · John D. Sheppard, M.D. (2) · Ahmed A Abdelshafy, MD (1) · Fatma Alibaz-Oner, Prof (1) · Flavio Leonin Jr., MD (1) · Ina Koetter, MD (1) · Kazuoki Kondo, MD (1) · LuzElena Concha-Del Rio, MD (1) · Masoud Soheilian, MD (1)
PMID 23290985, PMID 36399237, PMID 36787524, PMID 12095806, PMID 21220619, PMID 23411886, PMID 23761087, PMID 27310969, PMID 29370572, PMID 31722152, PMID 33157077, PMID 34322164, PMID 34741564, PMID 35798511, PMID 36055922, PMID 36578194, PMID 37316690, PMID 38027419
2009 (6), 2023 (2), 2014 (1)